Wipfli Financial Advisors’s Exact Sciences EXAS Stock Holding History

Wipfli Financial Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$62K	Buy	+1,903	New	+$78.5K	﹤0.01%	967

Other funds holding EXAS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wipfli Financial Advisors's EXAS Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Exact Sciences (EXAS) in Q3 2022: 1,903 shares worth $62K. The stake represents ﹤0.01% of the portfolio and ranks #967 among its holdings.

479 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

Wipfli Financial Advisors held 1,903 shares of Exact Sciences worth $62K as of Q3 2022.
Exact Sciences was a new Wipfli Financial Advisors position in Q3 2022.
Exact Sciences made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #967 holding.
479 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.